2002-2006 PhD: Fudan University, Department of Immunology
1991-1994 Master's: Shanghai Medical College, Department of Immunology
1983-1989 Bachelor's: Shanghai Medical College, Department of Clinical Medicine
Shuguang Scholar, Shanghai, 2004
2014.03-present - Fudan University - Secretary of the Party Committee, Institute of Biomedical Sciences
2012.10-2014.02 - Fudan University - Deputy Dean, Graduate School
2011.05-2014.02 - Fudan University - Director, Office of Medical Degree and Graduate Education Management
2007.06-2012.07 - Fudan University Shanghai Medical College - Deputy Secretary of the Party Committee
2013.06-present - Fudan University - Head, Department of Immunology, School of Basic Medical Sciences
2010.11-present - Fudan University - Director, Center for Biotherapy
2007.04-present - Fudan University - Professor, Department of Immunology, School of Basic Medical Sciences
2003.7-2004.5, 1997.2-1998.8 - Visiting Scholar, EACRI Cancer Research Center, USA
1995.11-1997.2 - Postdoctoral Fellow, University of Washington, Seattle, USA
2019-present - Vice President, Chinese Society of Immunology
2014-present - Vice President, Shanghai Society of Immunology
Shanghai Natural Science Award Second Prize (2020): First Author
Shanghai Medical Science Award Third Prize (2020): First Author
Shanghai Medical Science and Technology Award First Prize (2019): First Author
31st Shanghai Excellent Invention Award (2019): First Author
Baosteel Education Fund Excellent Teacher Award (2019)
Zhong Yang Style Good Teacher (2019)
Shanghai Teaching Achievement Award Second Prize (2018): First Author
Fudan University Teaching Achievement Award First Prize (2017): First Author
Shanghai Higher Education Boutique Course 'Medical Immunology' (2016): Responsible Person
Ministry of Education First Batch of English Teaching Brand Courses 'Immunology' (2013): Responsible Person
Research
Tumor Immunology and Immunobiotherapy Immunological Mechanisms of Inflammation-Cancer Transformation B Lymphocytes and Immune Regulation
Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion, Wang Z, Lu Z, Lin S, Xia J, Zhong Z, Xie Z, Xing Y, Qie J, Jiao M, Li Y, Wen H, Zhao P, Zhang D, Zhou P, Qian J, Luo F, Wang L, Yu H, Liu J, Gu J, Liu R, Chu Y, 2022
Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma, Lu Z, Liu R, Wang Y, Jiao M, Li Z, Wang Z, Huang C, Shi G, Ke A, Wang L, Fu Y, Xia J, Wen H, Zhou J, Wang X, Ye D, Fan J, Chu Y, Cai J, 2022
Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor, Yuedi Wang, Yiyuan Gao, Congyi Niu, Bo Wang, Shushu Zhao, Gils Roex, Jiawen Qian, Jingbo Qie, Lin Chen, Chenhe Yi, Sébastien Anguille, Jie Liu, Feifei Luo, Yiwei Chu, 2022
Editorial: Insights into Regulatory B Cells, Luman Wang, Damo Xu, Yiwei Chu, 2022
Immunometabolism shapes B cell fate and functions, Ying Fu, Luman Wang, Baichao Yu, Damo Xu, Yiwei Chu, 2022
Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway, Wanwei Zheng, Huan Song, Zhongguang Luo, Hao Wu, Lin Chen, Yuedi Wang, Haoshu Cui, Yufei Zhang, Bangting Wang, Wenshuai Li, Yao Liu, Jun Zhang, Yiwei Chu, Feifei Luo, Jie Liu, 2021
Deceleration of glycometabolism impedes IgG-producing B cell-mediated tumor elimination by targeting SATB1, Liu J, Li Y, Lu Z, Gu J, Liang Y, Huang E, Wang Z, Zhang H, Wang L, Zhang D, Yu H, Liu R, Chu Y, 2019
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy, Qian J, Wang C, Wang B, Yang J, Wang Y, Luo F, Xu J, Zhao C, Liu R, Chu Y, 2018
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial, Yao Y, Luo F, Tang C, Chen D, Qin Z, Hua W, Xu M, Zhong P, Yu S, Chen D, Ding X, Zhang Y, Zheng X, Yang J, Qian J, Deng Y, Hoon DSB, Hu J, Chu Y, Zhou L, 2018
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia, Qian J, Luo F, Yang J, Liu J, Liu R, Wang L, Wang C, Deng Y, Lu Z, Wang Y, Lu M, Wang JY, Chu Y, 2018
Peyer's patches-derived CD11b+ B cells recruit regulatory T cells through CXCL9 in dextran sulphate sodium-induced colitis, Wang Z, Zhang H, Liu R, Qian T, Liu J, Huang E, Lu Z, Zhao C, Wang L, Chu Y, 2018
MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors, Liu R, Lu Z, Gu J, Liu J, Huang E, Liu X, Wang L, Yang J, Deng Y, Qian J, Luo F, Wang Z, Zhang H, Jiang X, Zhang D, Qian J, Liu G, Zhu H, Qian Y, Liu Z, Chu Y, 2018
MiR-15a/16-1 Suppresses AHR-dependent IL-22 Secretion in CD4+ T cells and Contributes to Immune-mediated Organ Injury, Lu Z, Liu J, Liu X, Huang E, Yang J, Qian J, Zhang D, Liu R, Chu Y, 2018
New Chimeric Antigen Receptor Design for Solid Tumors, Wang Y, Luo F, Yang J, Zhao C, Chu Y, 2017
MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR, Yang J, Liu R, Deng Y, Qian J, Lu Z, Wang Y, Zhang D, Luo F, Chu Y, 2017
Bifunctional αHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2(+) gastric cancer, Luo F, Qian J, Yang J, Deng Y, Zheng X, Liu J, Chu Y, 2016
B cells expressing CD11b effectively inhibit CD4+ T cell responses and ameliorate experimental autoimmune hepatitis in mice, Liu X, Jiang X, Liu R, Wang L, Qian T, Zheng Y, Deng Y, Huang E, Xu F, Chu Y, 2015
T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis, L Wang, A Ray, X Jiang, J-y Wang, S Basu, X Liu, T Qian, R He, BN Dittel and Y Chu, 2015
DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling, Ronghua Liu, Jie Gu, Pei Jiang, Yijie Zheng, Xiaoming Liu, Xuechao Jiang, Enyu Huang, Shudao Xiong, Fengkai Xu, Guangwei Liu, Di Ge, Yiwei Chu, 2015
TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells, Zhang, Feifei Luo, Yuchan Cai, Nan Liu, Luman Wang,
